BE684147A - - Google Patents
Info
- Publication number
- BE684147A BE684147A BE684147DA BE684147A BE 684147 A BE684147 A BE 684147A BE 684147D A BE684147D A BE 684147DA BE 684147 A BE684147 A BE 684147A
- Authority
- BE
- Belgium
- Prior art keywords
- composition according
- edema
- units
- tablets
- day
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR25552A FR4920M (ref) | 1965-07-22 | 1965-07-22 | |
| FR25551A FR4843M (ref) | 1965-07-22 | 1965-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE684147A true BE684147A (ref) | 1966-12-16 |
Family
ID=26164941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE684147D BE684147A (ref) | 1965-07-22 | 1966-07-14 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE684147A (ref) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0072947A3 (en) * | 1981-08-10 | 1983-07-27 | Kaken Chemical Company, Ltd. | Agent for the prevention and treatment of liver and kidney diseases |
-
1966
- 1966-07-14 BE BE684147D patent/BE684147A/fr not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0072947A3 (en) * | 1981-08-10 | 1983-07-27 | Kaken Chemical Company, Ltd. | Agent for the prevention and treatment of liver and kidney diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boursinos et al. | Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing | |
| ES2525041T3 (es) | Método para la mejora de la señalización de islotes en diabetes mellitus y para su prevención | |
| US8075926B2 (en) | Herbal compositions for the treatment of mucosal lesions | |
| Alenzi et al. | Antiurolithic effect of olive oil in a mouse model of ethylene glycol-induced urolithiasis | |
| JPS6169722A (ja) | 医薬用組成物 | |
| JP5777906B2 (ja) | ロキソプロフェン又はその塩含有の医薬組成物 | |
| JP2016106138A (ja) | ロキソプロフェン又はその塩含有の医薬組成物<2> | |
| JP2000191542A (ja) | 骨粗鬆症予防、治療剤 | |
| EP2162491A1 (fr) | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage | |
| Fernandez-Segoviano et al. | Pulmonary vascular lesions in the toxic oil syndrome in Spain. | |
| Hostettmann et al. | Chemistry, biological, and pharmacological properties of African medicinal plants | |
| US6395313B1 (en) | Treatment of arthritis and other similar conditions | |
| Khandare et al. | Evaluation of antiulcer activity of polyherbal formulation | |
| Onayade et al. | Wound healing with plants: the African perspective | |
| US6855347B2 (en) | Composition for treating gastric ulcer and a process for preparing the same | |
| JPH05506847A (ja) | ククイナット外皮由来の抗ウイルス剤 | |
| JP2015166394A (ja) | ロキソプロフェン又はその塩含有の医薬組成物 | |
| CA2480223C (en) | A composition for treating gastric ulcer and a process for preparing the same | |
| CN104274540B (zh) | 含有雷公藤的中药组合物、其制备方法和用途 | |
| NL2030846B1 (en) | Pharmaceutical composition for preventing atherosclerosis and application thereof | |
| Borreli et al. | The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats | |
| Aboelgoud et al. | Effect of curcumin extracts on the islets of langerhans cells of diabetic white rats induced by Alloxan: a histological study | |
| RU2139071C1 (ru) | Средство для лечения хронического гепатита неинфекционной этиологии, осложненного хроническим панкреатитом | |
| KR100443653B1 (ko) | 월경 곤란증 치료효과가 있는 건강식품 | |
| KR20070099126A (ko) | 항염증 활성을 갖는 미역 추출물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: SOPHARMA S.A. Effective date: 19860714 |